Roth Capital Issues Pessimistic Forecast for Core Scientific (NASDAQ:CORZ) Stock Price

Core Scientific (NASDAQ:CORZ) had its price objective decreased by Roth Capital from $20.00 to $17.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Roth Capital’s target price would suggest a potential upside of 25.46% from the stock’s current price. Roth Capital also issued estimates for Core Scientific’s Q4 2026 earnings at $0.01 EPS, FY2027 earnings at $0.16 EPS and FY2028 earnings at $0.99 EPS.

Several other equities research analysts have also recently weighed in on CORZ. Jefferies Financial Group increased their target price on Core Scientific from $16.00 to $22.00 and gave the company a “buy” rating in a report on Monday, August 18th. Barclays cut Core Scientific to an “underweight” rating in a report on Tuesday, July 8th. Citigroup cut Core Scientific from an “outperform” rating to a “market perform” rating in a report on Monday, July 14th. Needham & Company LLC cut Core Scientific from a “moderate buy” rating to a “hold” rating and set a $18.00 target price for the company. in a report on Thursday, July 10th. Finally, HC Wainwright restated a “neutral” rating on shares of Core Scientific in a report on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $18.32.

Core Scientific Price Performance

Shares of CORZ stock opened at $13.55 on Friday. The stock has a market capitalization of $4.14 billion, a PE ratio of -24.20 and a beta of 6.60. Core Scientific has a 1-year low of $6.20 and a 1-year high of $18.63. The business has a 50-day moving average of $13.97 and a 200 day moving average of $11.07.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Friday, August 8th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.03. The company had revenue of $78.63 million for the quarter, compared to analysts’ expectations of $82.09 million. The business’s revenue was down 44.3% on a year-over-year basis. Analysts anticipate that Core Scientific will post 0.52 EPS for the current year.

Insider Buying and Selling

In other Core Scientific news, Director Yadin Rozov purchased 110,000 shares of the stock in a transaction on Wednesday, May 28th. The stock was acquired at an average price of $10.87 per share, with a total value of $1,195,700.00. Following the transaction, the director directly owned 475,687 shares of the company’s stock, valued at approximately $5,170,717.69. This trade represents a 30.08% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Todd M. Duchene sold 60,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $11.33, for a total value of $679,800.00. Following the transaction, the insider directly owned 2,100,102 shares of the company’s stock, valued at $23,794,155.66. The trade was a 2.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 117,759 shares of company stock valued at $1,391,434 in the last ninety days. 1.40% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. HHM Wealth Advisors LLC raised its position in shares of Core Scientific by 96.5% in the 2nd quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock worth $33,000 after acquiring an additional 946 shares in the last quarter. State of Wyoming bought a new position in shares of Core Scientific in the 1st quarter worth approximately $34,000. Emerald Mutual Fund Advisers Trust bought a new position in shares of Core Scientific in the 1st quarter worth approximately $38,000. Advisors Asset Management Inc. raised its position in shares of Core Scientific by 68.3% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,690 shares of the company’s stock worth $46,000 after acquiring an additional 1,092 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Core Scientific in the 1st quarter worth approximately $50,000.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.